MDPI and ACS Style
Andrieu, C.; McNamee, N.; Larkin, A.-M.; Maguire, A.; Menon, R.; Mueller-Eisert, J.; Horgan, N.; Kennedy, S.; Gullo, G.; Crown, J.;
et al. Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes. Med. Sci. 2022, 10, 26.
https://doi.org/10.3390/medsci10020026
AMA Style
Andrieu C, McNamee N, Larkin A-M, Maguire A, Menon R, Mueller-Eisert J, Horgan N, Kennedy S, Gullo G, Crown J,
et al. Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes. Medical Sciences. 2022; 10(2):26.
https://doi.org/10.3390/medsci10020026
Chicago/Turabian Style
Andrieu, Charlotte, Niamh McNamee, Anne-Marie Larkin, Alanna Maguire, Roopika Menon, Judith Mueller-Eisert, Noel Horgan, Susan Kennedy, Giuseppe Gullo, John Crown,
and et al. 2022. "Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes" Medical Sciences 10, no. 2: 26.
https://doi.org/10.3390/medsci10020026